Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Aitchison

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
BMC Cancer|March 18, 2016
Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patientsAntonia K Roseweir, Tahir Qayyum, Zhi Lim, et al.
European Urology|November 6, 2016
Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be AnsweredGrant D Stewart, Michael Aitchison, Axel Bex, et al.
Lancet (London, England)|February 16, 2010
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trialMartin E Gore, Clare L Griffin, Barry Hancock, et al.
BMJ Open|June 14, 2019
Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing <b>NE</b>phron <b>S</b>paring <b>T</b>reatment (NEST) for small renal massesJoana B Neves, David Cullen, Lee Grant, et al.
BMC Cancer|March 1, 2018
Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionalsMariya Melnychuk, Cecilia Vindrola-Padros, Michael Aitchison, et al.
BJU International|July 7, 2025
Natural history of treated and untreated renal oncocytoma: a systematic review and meta-analysisFrancesco Edwards, Jack B Fanshawe, Joana Neves, et al.
European Urology|September 8, 2023
Nephron Sparing Treatment (NEST) for Small Renal Masses: A Feasibility Cohort-embedded Randomised Controlled Trial Comparing Percutaneous Cryoablation and Robot-assisted Partial NephrectomyJoana B Neves, Hannah Warren, Joseph Santiapillai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal CancerGrant D Stewart, Fiach C O'Mahony, Alexander Laird, et al.
Pilot and Feasibility Studies|May 13, 2026
Nephron Sparing Treatment (NEST) for small renal masses: understanding patients' and clinicians' experiences of a cohort-embedded randomised control trialVeronica Ranieri, Hannah Warren, Joana B Neves, et al.
BJU International|May 28, 2021
Growth and renal function dynamics of renal oncocytomas in patients on active surveillanceJoana B Neves, Rebecca Varley, Stefano Agnesi, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
BMC Cancer|March 18, 2016
Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patientsAntonia K Roseweir, Tahir Qayyum, Zhi Lim, et al.
European Urology|November 6, 2016
Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be AnsweredGrant D Stewart, Michael Aitchison, Axel Bex, et al.
Lancet (London, England)|February 16, 2010
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trialMartin E Gore, Clare L Griffin, Barry Hancock, et al.
BMJ Open|June 14, 2019
Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing <b>NE</b>phron <b>S</b>paring <b>T</b>reatment (NEST) for small renal massesJoana B Neves, David Cullen, Lee Grant, et al.
BMC Cancer|March 1, 2018
Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionalsMariya Melnychuk, Cecilia Vindrola-Padros, Michael Aitchison, et al.
BJU International|July 7, 2025
Natural history of treated and untreated renal oncocytoma: a systematic review and meta-analysisFrancesco Edwards, Jack B Fanshawe, Joana Neves, et al.
European Urology|September 8, 2023
Nephron Sparing Treatment (NEST) for Small Renal Masses: A Feasibility Cohort-embedded Randomised Controlled Trial Comparing Percutaneous Cryoablation and Robot-assisted Partial NephrectomyJoana B Neves, Hannah Warren, Joseph Santiapillai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal CancerGrant D Stewart, Fiach C O'Mahony, Alexander Laird, et al.
Pilot and Feasibility Studies|May 13, 2026
Nephron Sparing Treatment (NEST) for small renal masses: understanding patients' and clinicians' experiences of a cohort-embedded randomised control trialVeronica Ranieri, Hannah Warren, Joana B Neves, et al.
BJU International|May 28, 2021
Growth and renal function dynamics of renal oncocytomas in patients on active surveillanceJoana B Neves, Rebecca Varley, Stefano Agnesi, et al.
Pageof 4